Ionis Pharmaceuticals: Pioneering Precision Medicine (IONS)

Genetic engineering concept. Genetic testing. pharmacy. Regenerative medicine.

metamorworks/iStock via Getty Images

Ionis Pharmaceuticals (NASDAQ:IONS) is actively pursuing a strategy to progress a wholly-owned pipeline and fortify its position in the oligonucleotide therapeutics sector. Oligonucleotide therapeutics, an emerging drug class, present a novel method

Source link